Germany RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

Germany RUO Immunoassay Market Size:

Germany RUO Immunoassay market is set to witness a CAGR of 12.17%  from 2025 to 2030.

Germany's RUO Immunoassay market is expanding due to several factors. One of the primary reasons is the research for potential biomarkers of disease, used to screen large numbers of samples. Favorable investments are accelerating the market growth. Some recent examples are listed below:                            

The European Investment Bank (EIB) has signed a quasi-equity financing agreement of up to €20 million with Numares Health AG for their innovative solutions. The company will analyze biomarkers with advanced nuclear magnetic resonance and artificial intelligence to improve diagnostics. The company will use research and development to improve diagnostic quality for chronic kidney, heart, and liver diseases, as well as cancer and multiple sclerosis,

Similarly, DFG, the German Research Foundation will fund seven new Research Units, one new Clinical Research Unit, and new Research Units will receive a total funding of approximately €40 million. Currently, the DFG is providing funding for a total of 185 Research Units, along with 13 Clinical Research Units and 18 Centers for Advanced Studies in Humanities and Social Sciences. Aligned with this, Medipan GmbH based in Germany, is funded by the European Union and the State of Brandenburg. The company operates in radioimmunoassay products for the characterization of thyroid function, disease, and tumor markers, with its partners from nuclear medicine laboratories.     

Moreover, Cipla (EU) Limited, acquired a 10.35% stake in Ethris GmbH, in 2023 in Germany, a pre-clinical stage firm working on a mRNA platform. This will provide Cipla access to its mRNA platform and the mRNA-based products developed by Ethris.

Germany is one of the promising markets for medicinal and pharma products, in 2022, Germany was the largest EU exporter with a revenue of €68 billion, followed by Belgium €56 billion, and Ireland €42 billion. Pharmaceutical products were the main commodities traded in 2022, with 7.5% of the total trade of the country. 

The companies based in Germany, such as Euroimmun, received the required certificate for their quality management system following the new European Regulation on in vitro diagnostic medical devices (IVDR), in August 2023. 

Further, in July 2022, IDS launched IVDR Complaint Class A Products, for healthcare professionals. They also added 4 new assays Ultra-Sensitive AMH/MIS ELISA, picoAMH ELISA, Inhibin A ELISA, and Ultra-Sensitive Inhibin B ELISA, in May 2022.

Along with that, Siemens Healthineers AG listed in Germany, launched Atellica CI Analyzer, a compact testing system, that integrates immunoassay and clinical chemistry testing to alleviate labor shortage challenges and boost revenue growth, promoting flexibility and comparability. These developments open up opportunities catering to the growing need for ROU immunoassay solutions offered by German companies.

Germany RUO Immunoassay Market Scope:

Report Metric	Details
Growth Rate	CAGR of 12.17%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Sample Type Application End-User State
Geographical Segmentation	North Rhine-Westphalia, Bavaria, Baden Wurttemberg, Hesse, Lower Saxony
List of Major Companies in the Germany RUO Immunoassay Market	Merck KgaA (Germany) DIAsource Immunoassay SA Siemens Healthineers Euroimmun Medizinische Labordiagnostika AG PerkinElmer, Inc.
Customization Scope	Free report customization with purchase

 

Germany RUO Immunoassay Market Segmentation

By Product Type

• Immunoassay Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
    • Conventional
    • Manual
  • Radioimmunoassay (RIA Kits)
    • Conventional
    • Manual
  • Chemiluminescent Immunoassay (CLIA) Kits
• Immunoassay Reagents
• Microplate Reader
• Microplates
• Analyzers
  • Automated Analyzers
  • Non-Automated Analyzers
• Microplate Washers
• Others

By Sample Type

• Plasma
• Blood Serum
• Urine
• Saliva
• Cell or Tissue Culture Medium
• Others

By Application

• Oncology
• Blood Screening and Toxicology
• Infectious Disease
• Cardiology
• Allergy Diagnostic
• Rare and Emerging Condition Diagnostic
• Others

By End-User

• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies

By State

• North Rhine-Westphalia
• Bavaria
• Baden Wurttemberg
• Hesse
• Lower Saxony

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

4.1. Product Pipeline

5. GERMANY RUO IMMUNOASSAY MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Immunoassay Kits

5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits

5.2.1.1. Conventional 

5.2.1.2. Manual

5.2.2. Radioimmunoassay (RIA Kits)

5.2.2.1. Conventional 

5.2.2.2. Manual

5.2.3. Chemiluminescent Immunoassay (CLIA) Kits

5.3. Immunoassay Reagents

5.4. Microplate Reader

5.5. Microplates

5.6. Analyzers

5.6.1. Automated Analyzers

5.6.2. Non-Automated Analyzers

5.7. Microplate Washers

5.8. Others

6. GERMANY RUO IMMUNOASSAY MARKET BY SAMPLE TYPE

6.1. Introduction

6.2. Plasma 

6.3. Blood Serum

6.4. Urine

6.5. Saliva

6.6. Cell or Tissue Culture Medium

6.7. Others

7. GERMANY RUO IMMUNOASSAY MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Blood Screening and Toxicology

7.4. Infectious Disease

7.5. Cardiology

7.6. Allergy Diagnostic

7.7. Rare and Emerging Condition Diagnostic

7.8. Others

8. GERMANY RUO IMMUNOASSAY MARKET BY END-USER

8.1. Introduction

8.2. Research and Academic Laboratories

8.3. Pharmaceutical and Biotechnology Companies

9. GERMANY RUO IMMUNOASSAY MARKET BY STATE

9.1. Introduction

9.2. North Rhine-Westphalia

9.2.1. By Product Type

9.2.2. By Sample Type

9.2.3. By Application

9.2.4. By End-User

9.3. Bavaria

9.3.1. By Product Type

9.3.2. By Sample Type

9.3.3. By Application

9.3.4. By End-User

9.4. Baden Wurttemberg

9.4.1. By Product Type

9.4.2. By Sample Type

9.4.3. By Application

9.4.4. By End-User

9.5. Hesse

9.5.1. By Product Type

9.5.2. By Sample Type

9.5.3. By Application

9.5.4. By End-User

9.6. Lower Saxony

9.6.1. By Product Type

9.6.2. By Sample Type

9.6.3. By Application

9.6.4. By End-User

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Merck KgaA (Germany)

11.2. DIAsource Immunoassay SA

11.3. Siemens Healthineers

11.4. Euroimmun Medizinische Labordiagnostika AG

11.5. PerkinElmer, Inc.

11.6. Danahar

11.7. F-Hoffmann-La Roche Ltd

11.8. BioCheck, Inc.

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations

Merck KgaA (Germany)

DIAsource Immunoassay SA

Siemens Healthineers

Euroimmun Medizinische Labordiagnostika AG

PerkinElmer, Inc.

Danahar

F-Hoffmann-La Roche Ltd

BioCheck, Inc.